Skip to main content

Day: May 7, 2020

REPEAT – Dorel Industries Will Hold a Conference Call to Discuss Its First Quarter Results

MONTREAL, May 07, 2020 (GLOBE NEWSWIRE) — Dorel Industries (TSX: DII.B, DII.A)THE PRESS RELEASE WILL BE PUBLISHED BEFORE MARKETS OPEN THE SAME DAY THROUGH GLOBENEWSWIRE.Please dial in 15 minutes before the conference begins.If you are unable to call in at this time, you may access a recording of the meeting by calling 1-800-585-8367 and entering the passcode 9741847 on your phone. This recording will be available on Friday, May 8, 2020 as of 4:00 PM until 11:59 PM on Friday, May 15, 2020.MEDIA WISHING TO QUOTE AN ANALYST SHOULD CONTACT THE ANALYST PERSONALLY FOR PERMISSION.Interested parties may also listen to a live webcast at https://www.dorel.com/eng/shareholder-information.For further information contact Rick Leckner, MaisonBrison at 514-731-0000.

Continue reading

Chicken Soup for the Soul Entertainment to Host First Quarter 2020 Conference Call on May 14, 2020

COS COB, Conn., May 07, 2020 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment, Inc. (Nasdaq: CSSE), one of the largest operators of streaming advertising-supported video-on-demand (AVOD) networks, today announced it will host a conference call and live webcast to discuss the results of its first quarter ended March 31, 2020.Conference Call InformationTo participate in this event, dial in approximately 5 to 10 minutes before the beginning of the call.Date, Time: Thursday, May 14, 2020, 4:30 p.m. ET.Toll-free: (833) 832-5128International: (484) 747-6583Conference ID: 7998306A live webcast is available at http://ir.cssentertainment.com/ under the “News & Events” tabConference Call Replay InformationToll-free: (855) 859-2056International: (404) 537-3406Reference ID: 7998306ABOUT CHICKEN SOUP FOR THE SOUL ENTERTAINMENTChicken...

Continue reading

Entera Bio to Report Interim Data From EB613 Phase 2 Trial and First Quarter 2020 Business and Financial Results on May 21, 2020

BOSTON and JERUSALEM, May 07, 2020 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced it will report interim three-month top-line biomarker data for the first 50% of the patients enrolled in the Phase 2 osteoporosis clinical trial of EB613 and financial and business results for the quarter ended March 31, 2020, on May 21, 2020, before the U.S. financial markets open. Entera’s management will host a conference call on Thursday, May 21, 2020 at 8:30 a.m. EDT to present the data and discuss the results for the quarter. A question-and-answer session will follow Entera’s remarks. To participate on the live call, please dial (855) 547-3865 (US) or (409) 217-8787 (international) and provide the conference ID “8441279” five to ten minutes before the start...

Continue reading

Workday Announces Date of Fiscal 2021 First Quarter Financial Results

PLEASANTON, Calif., May 07, 2020 (GLOBE NEWSWIRE) — Workday, Inc. (NASDAQ: WDAY), a leader in enterprise cloud applications for finance and human resources, plans to announce its fiscal 2021 first quarter financial results after market close on Thursday, May 28, 2020. The company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to review its financial results and business outlook.A live webcast of the event will be available on the Workday Investor Relations site. The replay of the webcast will be available for a minimum of 90 days after the conference call.About WorkdayWorkday is a leading provider of enterprise cloud applications for finance and human resources. Founded in 2005, Workday delivers financial management, human capital management, planning, and analytics applications designed for the world’s...

Continue reading

Atlas Air and Southern Air Provide Interim Pay Increase for Pilots in Agreement with International Brotherhood of Teamsters

PURCHASE, N.Y., May 07, 2020 (GLOBE NEWSWIRE) — Atlas Air Worldwide Holdings, Inc. (Nasdaq: AAWW) today announced that its wholly-owned subsidiaries Atlas Air, Inc. and Southern Air, Inc. have reached an agreement with International Brotherhood of Teamsters (IBT) Locals 2750 and 1224 for an interim pay increase for their pilots.  The ten percent pay increase is effective as of May 1.“We wanted to provide this interim increase to our pilots who are working so hard during this difficult time.  Reaching this agreement with our IBT Locals underscores our deep appreciation of the efforts of our pilots,” said John W. Dietrich, President and Chief Executive Officer, Atlas Air Worldwide.  “While we continue to manage through this current pandemic situation, we also remain focused on completing the joint collective bargaining agreement we...

Continue reading

FLEURY MICHON : Déclaration mensuelle rachat d’actions 04 2020

CONTRAT DE LIQUIDITE ET OU PROGRAMME DE RACHATTABLEAU DE DECLARATION MENSUELLE DES OPERATIONS REALISEESPAR UN EMETTEUR SUR SES PROPRES TITRESINFORMATIONS CUMULEES Nombre de titres composant le capital de l’émetteur au début du programme                4 387 757Capital auto détenu de manière directe et indirecte au début du programme (en titres + %) :…Exercice d’options attribuées aux salariés, de titres de créances donnant accès au capital A la date d’établissement de la présente déclaration Pièce jointe2020 04 Rachat Actions

Continue reading

Cellectar Reports First Quarter 2020 Financial Results and Provides a Corporate Update

FLORHAM PARK, N.J., May 07, 2020 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced financial results for the three months ended March 31, 2020 and provided a corporate update.First Quarter and Recent Corporate HighlightsAnnounced CLR 131 achieved primary efficacy endpoints from its Phase 2 CLOVER-1 study in median third line relapsed/refractory (r/r) and Non-Hodgkin’s lymphomas (NHL) and median sixth line r/r multiple myeloma (MM) and in the Phase 1 r/r MM dose escalation study at the 50mCi and 75mCi total body doses. The 75mCi total body dose demonstrated: Overall response rate (ORR) 42.8% in r/r MM33% ORR in triple class refractory r/r MM50% ORR in high risk r/r...

Continue reading

8i Enterprises Acquisition Corp. Announces Amendment to Agreement with Diginex Limited for Business Combination

NEW YORK, May 07, 2020 (GLOBE NEWSWIRE) — 8i Enterprises Acquisition Corp. (NASDAQ: JFKKU, JFK, JFKKW, JFKKR) (“JFK” or the “Company”), a special purpose acquisition company, today announced that it has amended the Share Exchange Agreement (“Amendment”) with Diginex Limited (“Diginex” or the “Company”), a blockchain financial services and technology company, to extend the date by which it much complete its business combination to June 23, 2020 and to include new covenants and closing conditions of the parties.JFK has called a special shareholder meeting for June 15, 2020 to vote on the business combination along with the other proposals. All parties remain committed to the business combination, which if consummated, will result in Diginex becoming the first company listed on Nasdaq with a digital asset exchange.The Amendment, among...

Continue reading

Ársreikningur Hafnarfjarðarbæjar 2019

Rekstrarafgangur ársins 2019 fyrir A og B hluta bæjarsjóðs nam 1.236 milljónum króna en áætlun ársins með viðaukum gerði ráð fyrir 642 milljóna króna afgangi. Rekstrarniðurstaða ársins fyrir A hluta var jákvæð um 426 milljónir króna en áætlun gerði ráð fyrir 45 milljóna króna halla.Mismun á áætlun og niðurstöðu má einkum rekja til þess að gjaldfærsla lífeyrissjóðsskuldbindingar var um 392 milljónum krónum lægri en gert hafði verið ráð fyrir. Fjármagnsliðir voru einnig um 245 milljónum krónum lægri en áætlun gerði ráð fyrir vegna lægri verðbótaþáttar. Veltufé frá rekstri nam 3.396 milljónum króna eða 11,9% af heildartekjum.„Við höfum stigið varfærin og ábyrg skref í rekstri sveitarfélagsins. Niðurstöður ársreiknings 2019 eru í takti við áætlanir okkar og samræmist markmiðum um ábyrga fjármálastjórn og vel ígrundaðar ákvarðanir,“ segir...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.